Becker's Healthcare November 27, 2024
A recent study using data from the UK BioBank highlighted the extended risk of major adverse cardiac events in individuals who have recovered from COVID-19.
The research, conducted by scientists from the University of Southern California in Los Angeles and Cleveland Clinic and published Oct. 9 in Arteriosclerosis, Thrombosis, and Vascular Biology, underscores the long-term cardiovascular impact of the virus, particularly for those who were hospitalized.
Here are four key findings:
- COVID-19 patients face an elevated risk of MACE, including heart attack, stroke and all-cause mortality, that persists for more than two years after infection. The study found that the risk of MACE remained significantly higher for COVID-19 patients compared to the general population, even beyond...